Education Information

This activity is supported by independent educational grants from:

  • Abbvie
  • Aimmune Therapeutics
  • ALK – Abello Inc
  • CSL Behring
  • DBV Technologies
  • GlaxoSmithKline
  • Merck & Co., Inc.
  • Pfizer, Inc.
  • Stallergenes Greer
  • Teva Pharmaceuticals

This activity is also supported by independent educational grants consisting of loaned durable equipment and disposable supplies from:

  • Micro Direct, Inc.
  • Optim LLC
  • RMS Medical Products
  • SmartPractice

Target Audience

Medical professionals who treat patients with allergic and/or immunological conditions:

  • Practicing allergist/immunologists
  • Academic allergists including training program and division directors
  • Allergy/immunology Fellows-in-Training
  • Physician assistants and advanced practice nurses
  • Allied health professionals
  • Primary care physicians and other medical professionals

“I found this to be a wonderful meeting and love the new educational formats. Speakers did an outstanding job overall summarizing the history of the evidence basis for treatment and providing key takeaways. Monday's MOC Continuous Assessment Program Review Session was outstanding! Should be included every year.”

– 2018 Annual Meeting Attendee

Overall Educational Objectives

At the conclusion of this activity, participants should be able to:

  • Identify major advances in key areas of cutting-edge research in immunologic mechanisms and allergic responses, including anaphylaxis and pathophysiology of the upper airways, lungs, eyes, skin and gastrointestinal tract.
  • Demonstrate knowledge of basic processes linking molecular and cellular biology and genetics with allergic pathophysiology and immunodeficiency.
  • Translate emerging clinical science principles to clinical practice in patients with allergic and immunologic diseases.
  • Evaluate and implement state-of-the-art diagnostic and therapeutic strategies for treating patients with allergic and immunologic diseases.
  • Explain the impact of environmental exposures and external influences on patients with allergic disorders.
  • Recognize emerging trends in the prevalence of allergic and immunologic disorders and discuss their impact on public health.
  • Evaluate the impact of new diagnostic and therapeutic strategies on health care costs and outcomes.
  • Discuss processes, tools and technologies for the efficient allergy and immunology practice.

Accreditation Statements

The American College of Allergy, Asthma & Immunology (ACAAI) is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education for physicians.

The American College of Allergy, Asthma & Immunology (ACAAI) is a provider, approved by the California Board of Registered Nursing, Provider Number CEP17239, for 34 contact hours.

Disclosure Statement

As required by the Accreditation Council for Continuing Medical Education (ACCME) and in accordance with the American College of Allergy, Asthma & Immunology (ACAAI) policy, the College must identify and resolve conflicts of interest for all individuals responsible for the development, management, presentation, and/ or evaluation relevant to a CME activity. Disclosed information is reviewed in advance in order to manage and resolve any potential conflicts of interest. Disclosure in no way implies that the information presented is biased or of lesser quality; it is incumbent upon course participants to be aware of these factors in interpreting the program contents and evaluating recommendations.

Specific disclosure information for the 2019 Annual Meeting is available online and via the meeting app

Credit Designation

The American College of Allergy, Asthma & Immunology (ACAAI) designates this live activity for a maximum of 34 AMA PRA Category 1 Credit(s). Physicians should claim only the credit commensurate with the extent of their participation in the activity.

The continuing medical education activity has been reviewed by the American Academy of Pediatrics (AAP) and is acceptable for a maximum of 34 AAP credits. These credits can be applied toward the AAP CME/CPD Award available to Fellows and Candidate Members of the AAP.

Advanced Practice Health Care Providers 1-Day Course: This activity has been designated for up to 6 Continuing Education contact hours.

Allied Health Professionals 2-Day Course: This activity has been designated for up to 7.5 Continuing Education contact hours.

Maintenance of Certification

The American Board of Allergy and Immunology’s (ABAI) Maintenance of Certifcation (MOC) program facilitates a physician’s commitment to lifelong learning. Part II of ABAI’s MOC program requires that diplomates obtain 25 CME credits in the areas of allergy and/or immunology on an annual basis. The CME credits for the Annual Meeting can be used to satisfy this requirement.

In addition to the required 25 CME credits, the ABAI recommends that six of the CME credits also qualify as Self-Assessment credit (aka MOC Part II credit).

ACAAI seamlessly transfers your Annual Meeting CME and MOC Part II credits to the ABAI at the end of the calendar year.

Please note that faculty cannot earn CME or MOC Part II credit for their presentations.

Core Competencies

ACAAI is committed to providing educational activities that align with the ABAI Core Competencies, which include:

  • Patient Care and Procedural Skills
  • Medical Knowledge
  • Practice-based Learning and Improvement
  • Interpersonal and Communication Skills
  • Professionalism
  • Systems-based Practice

Back to Top